Donate
Members
About Us
About ANZCHOG
Board of Directors
Our People
Our Members
Supporters & Partners
The Challenges of Childhood Cancer
Clinical Trials & Research
Clinical Trials
Clinical Trial Support
Research
ANZCHOG Biobanking Network
ANZCHOG Children’s Cancer Clinical Trials Repository
Cancer Information Registry for Children and Adolescents in Australia
Collaborations
Brain Cancer Mission
Background
Trials Advisory Group
Clinical Trials Supported
ASM
News
Events
Contact Us
Australian & New Zealand Childrens Haematology/Oncology Group
Donate
Members
About Us
About ANZCHOG
Board of Directors
Our People
Our Members
Supporters & Partners
The Challenges of Childhood Cancer
Clinical Trials & Research
Clinical Trials
Clinical Trial Support
Research
ANZCHOG Biobanking Network
ANZCHOG Children’s Cancer Clinical Trials Repository
Cancer Information Registry for Children and Adolescents in Australia
Collaborations
Brain Cancer Mission
Background
Trials Advisory Group
Clinical Trials Supported
ASM
News
Events
Contact Us
Clinical Trials
Home
Clinical Trials & Research
Clinical Trials
Viewing: Clinical Trials
Filter by
Closed to Recruitment
Preparing to Open
Open
In Development
Ewing Sarcoma
Status:
Open
|
QLD , WA
REGO-EWING: Phase Ib study of the combination of regorafenib with conventional chemotherapy for the treatment of newly diagnosed patients with multimetastatic Ewing Sarcoma
Read more
Acute Lymphoblastic Leukaemia
Status:
Preparing to Open
Interfant-21: Interfant-21: International collaborative treatment protocol for infants under one year with KMT2A rearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia
Read more
Hepatoblastoma/ hepatocellularcarcinoma
Status:
Closed to Recruitment
RELIVE: International registry for paediatric patients with relapsed or refractory hepatoblastoma or hepatocellular carcinoma
Read more
CNS Tumours
Status:
Open
|
NSW , QLD , VIC , WA
Deflexifol® at Relapse Trial (DART): Phase I/II Trial of Deflexifol for Refractory or Recurrent Paediatric Central Nervous System (CNS) Tumours
Read more
Craniopharyngioma
Status:
Preparing to Open
PNOC029: Nivolumab and DAY101 for the treatment of newly diagnosed or recurrent craniopharyngioma in children and young adults
Read more
Adamantinomatous Craniopharyngioma
Status:
Open
|
NSW , QLD , WA
CONNECT2108: Phase 2 Study of the MEK inhibitor MEKTOVI® (binimetinib) for the treatment of Progressive/Recurrent Pediatric Adamantinomatous Craniopharyngioma
Read more
First
Previous
1
2
3
Next
Last
All posts loaded.
All posts loaded.
Load more trials